| Literature DB >> 29399183 |
Peng Du1, Xinping Luan1, Yiwei Liao2, Yiti Mu1, Yang Yuan1, Jingxuan Xu1, Jingjing Zhang1.
Abstract
Malignant glioma is an aggressive type of cancer. Increasing evidence has suggested that microRNAs (miRs) regulate gene expression post-transcriptionally to affect cancer development and progression. Aberrant expression of miR-509-3p has been reported in cancer studies. However, the expression and mechanism of its function in glioma remains unclear. The present study demonstrated that miR-509-3p was downregulated in glioma tissue samples relative to non-tumor tissues, and that low miR-509-3p expression was associated with a reduced overall survival time. Functional studies revealed that the overexpression of miR-509-3p inhibited cell proliferation, induced apoptosis and suppressed cell migration and invasion via negatively regulating the expression of X-linked inhibitor of apoptosis. The data therefore suggested that miR-509-3p serves an important role in the development and progression of glioma, implicating its possible application in clinical practice as a biomarker and a potential novel therapeutic target.Entities:
Keywords: X-linked inhibitor of apoptosis; glioma; microRNA-509-3p
Year: 2017 PMID: 29399183 PMCID: PMC5772864 DOI: 10.3892/ol.2017.7390
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967